Leap Therapeutics Inc (NAS:LPTX)
$ 2.38 -0.09 (-3.64%) Market Cap: 91.07 Mil Enterprise Value: 36.73 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 46/100

Leap Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript

Jul 14, 2021 / 05:00PM GMT
Release Date Price: $14.3 (-1.38%)
Ahu Demir
Ladenburg Thalmann & Company Inc. - Analyst

Thank you for all joining us for the next presentation, Leap Therapeutics. We are now joined by Doug Onsi, the CEO; and Jay Baum, Vice President and Head of Translational Medicine of Leap Therapeutics. Doug, Jay, it's great to have you. Please feel free to take it away with your presentation, then we will follow up with a Q&A session after. Thank you.

Doug Onsi
Leap Therapeutics, Inc. - President & CEO

Great, thank you. Thank you very much, and good afternoon, everyone. It's a pleasure to be here at the Ladenburg Thalmann 2021 Healthcare Conference. I am Doug Onsi, the CEO of Leap; and I'm joined by our Vice President and Head of Translational Research, Jay Baum. And we're very proud to be able to give you an update on the clinical development of DKN-01 and the milestones ahead of us in what will be a very exciting second half of 2021.

My presentation today will include forward-looking statements, and I encourage you to review our SEC filings for all of the risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot